Insiders · Profile

Bonner Michael

Chief Financial Officer at CUMBERLAND PHARMACEUTICALS. Filing since 17 Nov 2016. CIK 0001666790

Company
Date
Role
Action
Shares
Amount
Of holding
29 Aug 2018
Chief Financial Officer
Bought
100
$624.00
0.5%
28 Aug 2018
Chief Financial Officer
Bought
300
$1.78K
1.7%
17 May 2018
Chief Financial Officer
Bought
400
$2.45K
2.3%
19 Mar 2018
Chief Financial Officer
Bought
300
$2.02K
1.9%
22 Nov 2017
Chief Financial Officer
Bought
250
$1.95K
1.6%
23 Aug 2017
Chief Financial Officer
Bought
500
$3.36K
3.3%
31 May 2017
Chief Financial Officer
Bought
300
$2.09K
2.0%
23 Mar 2017
Chief Financial Officer
Bought
900
$5.78K
7.6%
17 Nov 2016
Chief Financial Officer
Bought
900
$4.95K
8.2%
9 decisions on file.